2m 2m 2m 2m 2m 2m 2m
XTANT MEDICAL (XTNT)
NYSE
$0.46+$0.003 (+0.63%)
Price as of Jun 03, 2026 5:40 PM EDT- $64.8MMarket Cap
- -31.16%1-Year Change
- Medical DevicesIndustry
XTANT MEDICAL (XTNT)
$0.46+$0.003 (+0.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 115.2M -1.76% | 117.3M +28.44% | 91.3M +57.50% | 58.0M +4.90% | |
Cost of Revenue | 49.7M +1.23% | 49.1M +36.88% | 35.8M +38.73% | 25.8M +13.43% | |
Gross Profit | 84.3M +23.54% | 68.2M +22.98% | 55.5M +72.60% | 32.1M -1.09% | |
Sales and Marketing Expense | 45.5M -7.52% | 49.2M +28.03% | 38.4M +70.73% | 22.5M +7.09% | |
Research and Development Expense | -2.1M -11.87% | -2.4M +78.52% | -1.3M +46.01% | -915,000 +5.17% | |
Depreciation and Amortization Expense | 5.2M +23.65% | 4.2M +33.08% | 3.2M +145.67% | 1.3M -3.00% | |
Total Operating Expenses | 77.0M -4.11% | 80.3M +22.35% | 65.6M +68.74% | 38.9M +7.01% | |
Operating Profit | 7.3M +160.33% | -12.1M +18.86% | -10.2M +50.38% | -6.8M +75.27% | |
Interest Income | 94,000 N/A | N/A N/A | 149,000 +380.65% | 31,000 N/A | |
Interest Expense | -3.7M -11.75% | -4.2M +41.59% | -2.9M +73.64% | -1.7M +70.05% | |
Interest Income and Expense and Net | -3.6M -14.01% | -4.2M +49.16% | -2.8M +67.91% | -1.7M +66.93% | |
Total Nonoperating Income and Expense | -283,000 -93.24% | -4.2M -145.92% | 9.1M +649.13% | -1.7M +66.93% | |
Income before Taxes | 7.0M +143.05% | -16.3M +1,468.18% | -1.0M -87.68% | -8.4M +73.56% | |
Income Taxes | 2.0M +984.49% | 187,000 +111.02% | -1.7M -2,559.42% | 69,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 5.3M +132.15% | -16.4M -2,592.27% | 660,000 +107.78% | -8.5M +74.98% | |
Net Income from Continuing Operations Applicable to Common | 7.0M +143.05% | -16.3M +1,468.18% | -1.0M -87.68% | -8.4M +73.56% | |
Basic EPS and Net Income | 0.04 +133.33% | -0.12 -1,300.00% | 0.01 +111.11% | -0.09 +50.00% | |
Diluted EPS and Net Income | 0.03 +125.00% | -0.12 -1,300.00% | 0.01 +111.11% | -0.09 +50.00% | |
Basic Weighted Average Shares | 139.5M +4.39% | 133.7M +12.24% | 119.1M +26.58% | 94.1M +10.10% | |
Diluted Weighted Average Shares | 150.0M +12.25% | 133.7M +5.42% | 126.8M +34.76% | 94.1M +10.10% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 17.1M +175.09% | 6.2M +8.47% | 5.7M -71.84% | 20.3M +11.26% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 17.1M +175.09% | 6.2M +8.47% | 5.7M -71.84% | 20.3M +11.26% | |
Total Current Assets | 78.2M +16.58% | 67.1M +3.46% | 64.9M +31.53% | 49.3M +11.25% | |
Accumulated Depreciation | 22.2M +11.95% | 19.8M +0.80% | 19.7M +9.55% | 18.0M +4.63% | |
Property and Plant and Equipment and Net | 6.2M -38.78% | 10.1M +16.56% | 8.7M +50.25% | 5.8M +10.99% | |
Total Long-Term Assets | 133,000 +29.13% | 103,000 -26.95% | 141,000 -28.43% | 197,000 -31.36% | |
Total Assets | 94.1M +0.33% | 93.8M +1.32% | 92.6M +53.77% | 60.2M +10.12% | |
Income Taxes Payable | 5,000 -88.10% | 42,000 +100.00% | 21,000 N/A | N/A N/A | |
Total Short-Term Debt | 14.4M +18.46% | 12.1M +162.22% | 4.6M -19.08% | 5.7M +57.79% | |
Total Current Liabilities | 29.5M +3.16% | 28.6M +24.32% | 23.0M +51.07% | 15.2M +37.38% | |
Total Long-Term Debt | 11.0M -49.97% | 22.0M +28.37% | 17.2M +77.22% | 9.7M -17.82% | |
Total Long-Term Liabilities | 13.7M -38.53% | 22.3M +24.04% | 18.0M +68.57% | 10.7M -15.60% | |
Total Liabilities | 43.2M -15.10% | 50.9M +23.29% | 41.3M +58.35% | 26.1M +9.45% | |
Retained Earnings | -254.5M -1.92% | -259.5M +6.77% | -243.0M -0.27% | -243.7M +3.61% | |
Total Stockholders Equity | N/A N/A | 43.0M -16.33% | 51.3M +50.27% | 34.2M +10.65% | |
Total Shares Outstanding | 140.0M +0.71% | 139.0M +6.81% | 130.2M +19.57% | 108.9M +25.04% | |
Cash Flow | |||||
Cash from Operating Activities | 12.5M +205.46% | -11.9M +25.02% | -9.5M +78.15% | -5.3M -1,316.63% | |
Capital Expenditures | 2.4M -42.09% | 4.1M +182.49% | 1.5M -17.46% | 1.8M -16.60% | |
Cash from Investing Activities | 7.9M +311.77% | -3.7M -84.95% | -24.8M +1,489.74% | -1.6M -17.51% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -9.6M -159.54% | 16.1M -18.37% | 19.7M +118.30% | 9.0M -48.45% | |
Financials Ratio | |||||
Gross Margin | 56.90% -2.19% | 58.17% -4.25% | 60.75% +9.58% | 55.44% -5.70% | |
Operating Margin | 6.32% +161.41% | -10.30% -7.45% | -11.13% -4.52% | -11.65% +67.09% | |
Return on Assets | 5.63% +131.89% | -17.64% -2,143.13% | 0.86% +105.85% | -14.77% +46.42% | |
Return on Equity | N/A N/A | -34.88% -2,359.94% | 1.54% +105.92% | -26.09% +22.11% | |
Revenue Growth | -1.76% -106.19% | 28.44% -50.55% | 57.50% +1,074.35% | 4.90% +35.60% | |
Current Ratio | 2.65 +13.01% | 2.35 -16.77% | 2.82 -12.94% | 3.24 -19.02% | |
Cash Ratio | 0.58 +166.67% | 0.22 -12.75% | 0.25 -81.36% | 1.33 -19.01% | |
Debt-to-Equity Ratio | N/A N/A | 0.80 +87.39% | 0.42 -5.84% | 0.45 -9.68% | |
Debt-to-Assets Ratio | 0.27 -25.93% | 0.36 +54.70% | 0.24 -7.98% | 0.26 -9.23% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow